MX2019010599A - Medical uses for the treatment of retinitis pigmentosa. - Google Patents

Medical uses for the treatment of retinitis pigmentosa.

Info

Publication number
MX2019010599A
MX2019010599A MX2019010599A MX2019010599A MX2019010599A MX 2019010599 A MX2019010599 A MX 2019010599A MX 2019010599 A MX2019010599 A MX 2019010599A MX 2019010599 A MX2019010599 A MX 2019010599A MX 2019010599 A MX2019010599 A MX 2019010599A
Authority
MX
Mexico
Prior art keywords
retinitis pigmentosa
treatment
medical uses
cntf
aav
Prior art date
Application number
MX2019010599A
Other languages
Spanish (es)
Inventor
Maclaren Robert
Lipinski Daniel
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Innovation filed Critical Isis Innovation
Priority to MX2019010599A priority Critical patent/MX2019010599A/en
Publication of MX2019010599A publication Critical patent/MX2019010599A/en

Links

Abstract

The present invention discloses a method for treating or preventing retinitis pigmentosa consisting of administering an adeno-associated virus (AAV) vector with a nucleotide sequence encoding the ciliary neurotrophic factor (CNTF) to the subject that needs it.
MX2019010599A 2015-06-15 2015-06-15 Medical uses for the treatment of retinitis pigmentosa. MX2019010599A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2019010599A MX2019010599A (en) 2015-06-15 2015-06-15 Medical uses for the treatment of retinitis pigmentosa.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2019010599A MX2019010599A (en) 2015-06-15 2015-06-15 Medical uses for the treatment of retinitis pigmentosa.

Publications (1)

Publication Number Publication Date
MX2019010599A true MX2019010599A (en) 2019-10-24

Family

ID=69416632

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019010599A MX2019010599A (en) 2015-06-15 2015-06-15 Medical uses for the treatment of retinitis pigmentosa.

Country Status (1)

Country Link
MX (1) MX2019010599A (en)

Similar Documents

Publication Publication Date Title
IL291844B1 (en) Smc combination therapy for the treatment of cancer
PL3600281T3 (en) Combination therapy for the treatment or prevention of tumours
MX366343B (en) Gene therapy.
PT3303576T (en) Adenoassociated virus vectors for the treatment of mucopolysaccharidoses
SG11202105873SA (en) Combination therapy for treating muscular dystrophy
IL267795A (en) Combination therapy for the treatment of cancer
ECSP16083000A (en) GENE THERAPY FOR PIGMENTARY RETINITIS
MX2021006762A (en) Optimized rpe65 promoter and coding sequences.
MX2020006237A (en) Compounds for treatment of diseases related to dux4 expression.
PT3519569T (en) Adenoassociated virus vectors for the treatment of mucopolysaccharidoses
MX2018009325A (en) Compounds and methods of treating rna-mediated diseases.
NZ761519A (en) Nlrp3 modulators
MX2017016114A (en) Methods of treating or preventing a proteopathy.
MX2017014456A (en) Therapeutic uses of l-4-chlorokynurenine.
TW201613610A (en) Use of ginsenoside M1 for treating lupus nephritis
IL266993A (en) Combination therapy for the treatment of cancer
ZA201803080B (en) Methods of treating muscular dystrophy
WO2018183692A8 (en) Vectors and compositions for treating hemoglobinopathies
GB201800736D0 (en) Combination therapy for treatment of leukemia
MX2019011692A (en) Novel treatment of mitochondrial diseases.
MX2021002982A (en) Compositions and methods for treating retinitis pigmentosa.
MX2020008969A (en) Treatment and prevention of pre-eclampsia.
MX2019010599A (en) Medical uses for the treatment of retinitis pigmentosa.
MX2017013156A (en) Methods of treating diseases.
MX2015007650A (en) Treatment of retinitis pigmentosa.